Private Trust Company’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$100K Buy
191
+27
+16% +$14.2K 0.01% 955
2025
Q1
$104K Buy
164
+19
+13% +$12.1K 0.01% 933
2024
Q4
$103K Sell
145
-77
-35% -$54.8K 0.01% 912
2024
Q3
$233K Sell
222
-50
-18% -$52.6K 0.02% 642
2024
Q2
$286K Sell
272
-14
-5% -$14.7K 0.03% 538
2024
Q1
$275K Buy
286
+36
+14% +$34.7K 0.03% 533
2023
Q4
$220K Sell
250
-153
-38% -$134K 0.03% 578
2023
Q3
$332K Buy
403
+94
+30% +$77.4K 0.04% 425
2023
Q2
$222K Buy
309
+154
+99% +$111K 0.03% 529
2023
Q1
$127K Buy
155
+44
+40% +$36.2K 0.02% 686
2022
Q4
$80K Sell
111
-4
-3% -$2.88K 0.01% 811
2022
Q3
$79K Sell
115
-3
-3% -$2.06K 0.01% 750
2022
Q2
$70K Sell
118
-1,595
-93% -$946K 0.01% 817
2022
Q1
$1.2M Sell
1,713
-303
-15% -$212K 0.19% 138
2021
Q4
$1.27M Sell
2,016
-132
-6% -$83.4K 0.18% 141
2021
Q3
$1.3M Buy
2,148
+96
+5% +$58.1K 0.19% 132
2021
Q2
$1.15M Buy
2,052
+231
+13% +$129K 0.17% 144
2021
Q1
$861K Buy
1,821
+1,002
+122% +$474K 0.14% 174
2020
Q4
$395K Buy
819
+269
+49% +$130K 0.07% 276
2020
Q3
$307K Sell
550
-12
-2% -$6.7K 0.06% 288
2020
Q2
$349K Buy
+562
New +$349K 0.07% 262
2014
Q4
Sell
-405
Closed -$146K 979
2014
Q3
$146K Buy
405
+15
+4% +$5.41K 0.05% 321
2014
Q2
$110K Hold
390
0.04% 389
2014
Q1
$117K Buy
390
+200
+105% +$60K 0.04% 326
2013
Q4
$52K Buy
190
+184
+3,067% +$50.4K 0.02% 449
2013
Q3
$2K Sell
6
-84
-93% -$28K ﹤0.01% 1442
2013
Q2
$20K Buy
+90
New +$20K 0.01% 629